Stay updated on Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.

Latest updates to the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page
- Check3 days agoChange DetectedThe CI-8993 Phase 1 study record is displayed, including its design, eligibility criteria, treatment, outcomes, locations, and completed status; the prior view showed a 403 error.SummaryDifference46%

- Check10 days agoChange DetectedThe footer's ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA sitewide NIH notice about its terminology transition appears above the page, and the displayed site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe site revision identifier changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the usual study details and navigation. This indicates the page is currently inaccessible due to access restrictions.SummaryDifference18%

- Check59 days agoChange DetectedThe page's revision label changed from v3.6.6 to v3.7.0, indicating a software update to the page.SummaryDifference0.1%

Stay in the know with updates to Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study CI-8993 Anti-VISTA Antibody Clinical Trial page.